Employees Retirement System of Texas Has $79.84 Million Holdings in Stryker Corporation $SYK

Employees Retirement System of Texas boosted its holdings in Stryker Corporation (NYSE:SYK) by 27.6% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 201,800 shares of the medical technology company’s stock after acquiring an additional 43,600 shares during the quarter. Employees Retirement System of Texas owned 0.05% of Stryker worth $79,838,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Consolidated Portfolio Review Corp lifted its holdings in shares of Stryker by 4.2% in the second quarter. Consolidated Portfolio Review Corp now owns 648 shares of the medical technology company’s stock valued at $256,000 after purchasing an additional 26 shares in the last quarter. Princeton Global Asset Management LLC raised its position in Stryker by 16.9% in the 2nd quarter. Princeton Global Asset Management LLC now owns 180 shares of the medical technology company’s stock valued at $71,000 after buying an additional 26 shares during the last quarter. Sunflower Bank N.A. lifted its stake in Stryker by 4.0% during the 2nd quarter. Sunflower Bank N.A. now owns 696 shares of the medical technology company’s stock valued at $275,000 after acquiring an additional 27 shares in the last quarter. Pitti Group Wealth Management LLC boosted its holdings in Stryker by 3.2% during the 2nd quarter. Pitti Group Wealth Management LLC now owns 861 shares of the medical technology company’s stock worth $341,000 after acquiring an additional 27 shares during the last quarter. Finally, Sachetta LLC grew its stake in shares of Stryker by 58.7% in the 2nd quarter. Sachetta LLC now owns 73 shares of the medical technology company’s stock worth $29,000 after acquiring an additional 27 shares in the last quarter. 77.09% of the stock is owned by institutional investors.

Insider Buying and Selling at Stryker

In related news, CAO William E. Berry, Jr. sold 1,953 shares of the business’s stock in a transaction on Friday, November 14th. The stock was sold at an average price of $365.49, for a total transaction of $713,801.97. Following the sale, the chief accounting officer directly owned 2,833 shares in the company, valued at approximately $1,035,433.17. The trade was a 40.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Ronda E. Stryker sold 276,173 shares of the stock in a transaction dated Thursday, November 6th. The stock was sold at an average price of $353.28, for a total value of $97,566,397.44. Following the sale, the director directly owned 2,702,108 shares in the company, valued at $954,600,714.24. This trade represents a 9.27% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 522,118 shares of company stock valued at $185,381,932 in the last 90 days. 5.90% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on SYK shares. Rothschild & Co Redburn assumed coverage on shares of Stryker in a report on Thursday, September 18th. They set a “neutral” rating and a $420.00 price target on the stock. Truist Financial boosted their target price on Stryker from $392.00 to $400.00 and gave the stock a “hold” rating in a research note on Friday, November 14th. Redburn Partners set a $420.00 price target on Stryker in a research report on Thursday, September 18th. Evercore ISI cut their price objective on Stryker from $410.00 to $405.00 and set an “outperform” rating on the stock in a research report on Friday, October 31st. Finally, BTIG Research reaffirmed a “buy” rating and set a $410.00 target price on shares of Stryker in a research report on Friday, November 14th. Thirteen analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat, Stryker presently has a consensus rating of “Moderate Buy” and a consensus target price of $434.37.

Stryker Trading Up 1.3%

Shares of Stryker stock opened at $375.11 on Wednesday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.06 and a current ratio of 1.78. The stock has a market capitalization of $143.45 billion, a P/E ratio of 49.68, a P/E/G ratio of 2.66 and a beta of 0.94. Stryker Corporation has a 52-week low of $329.16 and a 52-week high of $406.19. The stock’s 50-day simple moving average is $369.22 and its 200 day simple moving average is $380.55.

Stryker (NYSE:SYK) last posted its earnings results on Thursday, October 30th. The medical technology company reported $3.19 earnings per share for the quarter, topping the consensus estimate of $3.13 by $0.06. The firm had revenue of $6.06 billion during the quarter, compared to the consensus estimate of $6.04 billion. Stryker had a net margin of 12.25% and a return on equity of 23.94%. The company’s revenue was up 10.2% on a year-over-year basis. During the same quarter last year, the company earned $2.87 earnings per share. Stryker has set its FY 2025 guidance at 13.500-13.600 EPS. As a group, research analysts anticipate that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.